Sanofi price target raised to EUR 117 from EUR 111 at Guggenheim

Guggenheim analyst Seamus Fernandez raised the firm’s price target on Sanofi to EUR 117 from EUR 111 and keeps a Buy rating on the shares after revising the firm’s model to account for Q2 results and prescription trends. The firm’s key model updates include increasing Altuviiio and Beyfortus peak sales forecasts, the analyst tells investors.